• SectorHealthcare
  • LocationAustin, TX
  • Invested2007
  • StatusActive
  • FundBiohealth

Apollo Endosurgery

apolloendo.com

Apollo Endosurgery is the leader in minimally invasive endoscopic surgical products for bariatric and gastrointestinal procedures.

Apollo Endosurgery is the leader in minimally invasive endoscopic surgical products for bariatric and gastrointestinal procedures. In December 2013, Apollo expanded the breadth of their innovative devices with the acquisition of the LAP-BAND® Adjustable Gastric Banding System and the Orbera™ Intra-Gastric Balloon System from Allergan, Inc. The addition of these breakthrough systems has positioned Apollo as the only company with FDA-approved devices for weight loss surgery in patients with a BMI of 30-40, allowing them to lead a new era of surgery worldwide and deliver on their brand promise of harnessing experience, innovation, and technology to help people live the lives they’ve always imagined.

Apollo’s second generation OverStitch™ Endoscopic Suturing System mimics surgical suturing, enabling full-thickness stitches of internal tissue without making incisions through the skin. Also in the endoscopic product portfolio is the FDA-cleared SuMO™ Endoscopic Tissue Access and Resection System. This scarless surgery system is designed to help surgeons remove large, flat precancerous gastrointestinal lesions and polyps during endoscopic procedures.

×